The protective role of OM-85 was abolished entirely in the absence of genes related to the type I IFN response, i.e., when A549 cells lacking the type I response pathway (IFNAR and RIG-I knockout cells) were used. The gene discussed is IFNAR1; the disease is ocular melanoma.